Description

2-((3-(3,4-Dihydro-2H-Benzo[B][1,4]Dioxepin-7-Yl)-2-Methyl-4-Oxo-4H-Chromen-7-Yl)Oxy)Acetonitrile is a high-purity, advanced pharmaceutical intermediate with a complex chromone-dioxepin fused structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities for various disease targets.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of complex drug candidates, especially those targeting central nervous system (CNS) disorders or inflammatory pathways.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chromone-based or benzodioxepin-containing compounds with potential biological activity.
• API Development: Integral to the research and process development stages for creating new Active Pharmaceutical Ingredients (APIs) under Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) environments.
• Chemical Biology Probes: Can be utilized in the design and synthesis of molecular probes for studying enzyme mechanisms or protein interactions in biochemical assays.
• Custom Synthesis: Available for contract research organizations (CROs) and custom synthesis houses requiring high-fidelity, complex intermediates for client-specific projects.

Basic Information

Product Name	2-((3-(3,4-Dihydro-2H-Benzo[B][1,4]Dioxepin-7-Yl)-2-Methyl-4-Oxo-4H-Chromen-7-Yl)Oxy)Acetonitrile
CAS No.	307509-04-2
Molecular Formula	C21H17NO5
Molecular Weight	363.36 g/mol
Synonyms	7-((Cyanomethoxy)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-4H-chromen-4-one; 2-[(3-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-4-oxo-4H-chromen-7-yl)oxy]acetonitrile; Chromone-dioxepin acetonitrile derivative; 307509-04-2; 2-((3-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-4-oxo-4H-chromen-7-yl)oxy)acetonitrile
EINECS	Contact for details

Quality Control

Our 2-((3-(3,4-Dihydro-2H-Benzo[B][1,4]Dioxepin-7-Yl)-2-Methyl-4-Oxo-4H-Chromen-7-Yl)Oxy)Acetonitrile is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis to ensure compliance with ICH Q3C guidelines. Certificates of Analysis (COA) detailing all specifications and test results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.